Physician profile
Wayne Axman
NPI 1922043033
$14,021.63
in general payments reported to CMS, 2019-2025
45 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 86% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $447 · 2021: $376 · 2022: $668 · 2023: $615 · 2024: $10K · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $8,908 · Food and Beverage: $2,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $8,908.40 |
| Food and Beverage | $2,793.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $10,002.98 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $646.15 | 2019-2024 | Phalinx, Citrefix |
| Smith+Nephew, INC. | $621.51 | 2019-2024 | Collagenase Santyl, Pico 7, Grafix Pl |
| Xeris Pharmaceuticals, INC. | $267.98 | 2024-2025 | Gvoke Hypopen |
| Treace Medical Concepts, INC. | $208.85 | 2023-2024 | |
| Advanced Oxygen Therapy INC. | $195.75 | 2022-2025 | Topical Oxygen Chamber For Extremities |
| Inari Medical, INC. | $194.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Polynovo North America LLC | $173.48 | 2022-2024 | Novosorb Btm |
| Lilly USA, LLC | $168.82 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $113.02 | 2020-2024 | Xarelto |
| Biocomposites INC | $108.77 | 2021-2025 | Stimulan |
| Bioventus LLC | $101.72 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $92.04 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Osteomed LLC | $90.50 | 2019 | |
| Chiesi USA, INC. | $86.47 | 2024-2025 | Mycapssa |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $80.96 | 2023-2024 | Korlym |
| Orthofix Medical, INC. | $67.50 | 2022-2024 | Physio-Stim |
| Medartis INC. | $64.93 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $64.66 | 2019-2021 | |
| Organogenesis INC. | $52.64 | 2020-2021 | |
| Nevro Corp. | $50.50 | 2022-2023 | Senza |
| Abbvie INC. | $48.32 | 2022-2023 | Dalvance |
| Sanofi-Aventis U.S. LLC | $42.91 | 2020-2023 | |
| Novo Nordisk INC | $42.11 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.97 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $30.82 | 2022-2024 | Strensiq |
| Teva Pharmaceuticals USA, INC. | $23.34 | 2025 | Uzedy |
| Aroa Biosurgery Incorporated | $22.83 | 2024 | |
| Amgen INC. | $22.78 | 2023 | Repatha |
| Janssen Scientific Affairs, LLC | $22.13 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $21.88 | 2019 | |
| Mimedx Group, INC. | $21.00 | 2025 | |
| Vifor Pharma, INC. | $21.00 | 2020 | |
| Axogen | $20.57 | 2023 | Avance Nerve Graft |
| Medtronic, INC. | $19.45 | 2024 | Minimed 780g |
| Vivus LLC | $19.23 | 2019 | |
| Averitas Pharma INC. | $18.95 | 2023 | Qutenza |
| Kci USA, INC. | $18.86 | 2022 | |
| Acera Surgical, INC. | $18.80 | 2024 | Restrata Wound Matrix |
| Insulet Corporation | $18.16 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $17.93 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.91 | 2024 | |
| Hydrofera LLC | $15.50 | 2024 | Hydrofera Blue |
| Convatec INC. | $13.88 | 2023 | |
| Solventum Corporation | $13.26 | 2024 | V.A.C. Veraflo, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Axman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.